| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |